Journal for ImmunoTherapy of Cancer (Jul 2023)
Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
Abstract
No abstracts available.
